These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17161812)

  • 21. Biotransformation enzymes and drug transporters pharmacogenetics in relation to immunosuppressive drugs: impact on pharmacokinetics and clinical outcome.
    Mourad M; Wallemacq P; De Meyer M; Malaise J; De Pauw L; Eddour DC; Goffin E; Lerut J; Haufroid V
    Transplantation; 2008 Apr; 85(7 Suppl):S19-24. PubMed ID: 18401258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomics in gastrointestinal disorders.
    Camilleri M; Saito YA
    Methods Mol Biol; 2008; 448():395-412. PubMed ID: 18370239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nephrotic syndrome in the elderly. Treatment of the nephrotic syndrome in the elderly (part II)].
    Szmyt M; Niemir ZI; Czekalski S
    Pol Merkur Lekarski; 2007 Nov; 23(137):391-4. PubMed ID: 18361327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP3A polymorphisms and immunosuppressive drugs in solid-organ transplantation.
    Wang J
    Expert Rev Mol Diagn; 2009 May; 9(4):383-90. PubMed ID: 19435458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of immunosuppressive drugs in IBD: RAND or random choice?
    Vermeire S
    Dig Liver Dis; 2005 Jun; 37(6):391-3. PubMed ID: 15893276
    [No Abstract]   [Full Text] [Related]  

  • 26. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference.
    Wallemacq P; Armstrong VW; Brunet M; Haufroid V; Holt DW; Johnston A; Kuypers D; Le Meur Y; Marquet P; Oellerich M; Thervet E; Toenshoff B; Undre N; Weber LT; Westley IS; Mourad M
    Ther Drug Monit; 2009 Apr; 31(2):139-52. PubMed ID: 19177031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
    Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
    Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus.
    Askanase AD; Wallace DJ; Weisman MH; Tseng CE; Bernstein L; Belmont HM; Seidman E; Ishimori M; Izmirly PM; Buyon JP
    J Rheumatol; 2009 Jan; 36(1):89-95. PubMed ID: 19040311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Today in molecular mechanisms of immunosuppressive drugs actions: roles of pharmacist].
    Hulin A
    Ann Pharm Fr; 2008 Mar; 66(2):102-14. PubMed ID: 18570909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of steroid-resistant idiopathic nephrotic syndrome].
    Chemli J; Harbi A
    Arch Pediatr; 2009 Mar; 16(3):260-8. PubMed ID: 19195856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current and future therapies for inflammatory bowel disease.
    Zisman TL; Kane SV
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):89-100. PubMed ID: 19072438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An in vitro system for the determination of individualized immunosuppression.
    Linnebacher M; Blauscha C; Wacke R; Kottek T; Stein Sv; Kiefel V; Hakenberg OW; Klar E
    Transplant Proc; 2008 May; 40(4):918-20. PubMed ID: 18555078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation.
    Ciuffreda D; Pantaleo G; Pascual M
    Transpl Int; 2007 Aug; 20(8):649-58. PubMed ID: 17425723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy.
    Passarini B; Infusino SD; Barbieri E; Varotti E; Gionchetti P; Rizzello F; Morselli C; Tambasco R; Campieri M
    Dermatology; 2007; 215(4):295-300. PubMed ID: 17911986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
    Monteleone G; Pallone F; Macdonald TT
    Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of T-cell monitoring assays in kidney transplantation.
    Nickel P; Bestard O; Volk HD; Reinke P
    Curr Opin Organ Transplant; 2009 Aug; 14(4):426-31. PubMed ID: 19417657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between plasma leptin or soluble cleaved leptin-receptor concentrations and glucocorticoid sensitivity of peripheral blood mononuclear cells in patients with nephrotic syndrome.
    Henmi K; Yoshida M; Yoshikawa N; Nakabayashi I; Hirano T
    Int Immunopharmacol; 2008 Dec; 8(12):1703-6. PubMed ID: 18700169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunomodulatory drugs and their application to the management of canine immune-mediated disease.
    Whitley NT; Day MJ
    J Small Anim Pract; 2011 Feb; 52(2):70-85. PubMed ID: 21265846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive drugs in clinical medicine.
    ten Berge RJ; Schellekens PT
    Neth J Med; 1994 Dec; 45(6):329-38. PubMed ID: 7838250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
    Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
    Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.